Medytox Intensifies Southeast Asia Expansion... Signs 'Neuraderm' Supply Contract with Vietnamese Distributor

Medytox announced on the 19th that it has signed a supply contract for 'Neuraderm (NEURADERM)' with PCVN, a local distributor in Vietnam.

PCVN's DINH THI KIEU OANH CEO (left) and Ju Hee-seok, Vice President of Medytox, are taking a commemorative photo after signing a partnership agreement.
[Photo by Medytox]

PCVN is a medical device and cosmetics distributor with over 500 hospitals and spas across Vietnam as its main clients. It supplies its own brand and partner products through collaboration with doctors in more than 60 regions. In particular, ahead of this supply contract, the company acquired a firm specialized in online sales and plans to conduct aggressive online and offline sales and marketing in the future.

Through this partnership contract, Medytox will be able to strengthen synergy between distribution channels. Medytox plans to focus all efforts on entering the Southeast Asian market by utilizing the distribution networks of its overseas local subsidiaries and PCVN.

Joo Hee-seok, Vice President of Medytox, said, "The Vietnamese market is very attractive due to its large young population with a high tendency to consume cosmetics and its rapid growth rate among Asian countries. We will devote all efforts to expanding distribution channels including the Southeast Asian region to continuously establish a successful global market entry foundation for Neuraderm."

Neuraderm is a neuro-derma cosmetic brand independently developed by Medytox. To ensure the successful market settlement of 'Neuraderm,' Medytox reinforced its product lineup last March.

This content was produced with the assistance of AI translation services.